Zepp Health Reports Strong 2025 Revenue Growth Driven by Amazfit Success

Zepp Health (NYSE:ZEPP) reported a 41.8% increase in full-year revenue for 2025, fueled by strong demand for its Amazfit branded products. The company is currently pivoting from a traditional hardware manufacturer to a hybrid training platform, with Q1 2026 revenue projected between $50 million and $55 million.

How did Zepp Health perform in 2025?

The company saw significant momentum toward the end of the year, with Q4 revenue growing 43% year over year. This growth was supported by a shift toward higher-value segments, specifically the premium T-Rex and Balance series.

According to company reports, Zepp Health achieved record gross margins of 40.4% in the fourth quarter. This improvement resulted from a more favorable product mix and successful brand positioning in the premium market.

Did You Know? Since the beginning of 2023, Zepp Health has cumulatively retired $58 million in debt to optimize its capital structure.

Why is the company shifting to a hybrid platform?

Management is moving beyond simple hardware to create an ecosystem driven by AI-driven insights. CEO Wen noted that the company aims to use AI to improve efficiency within its R&D processes to sustain new product launches.

To build brand credibility, the company invested approximately $1 million in front-loaded marketing. This included partnerships with elite athletes, such as Olympic medalist Josh Kerr, and collaborations with hybrid endurance competitions.

Expert Insight: Samantha Carter suggests that Zepp Health’s transition to a “hybrid training platform” is a strategic move to escape the commodity trap of wearable hardware. By layering AI insights over physical devices, the company is likely attempting to create higher user switching costs and more sustainable recurring value.

What is the financial outlook for 2026?

Zepp Health expects a 30-43% year-over-year revenue increase for Q1 2026. Management believes this growth stems from structural demand rather than seasonal trends.

Generative AI-powered Smart Wearables | Amazfit | Zepp Health

The company maintains a strong balance sheet with a $113 million cash position. Because of these fundamentals, the company is reaffirming its commitment to its share repurchase program for 2026.

What happens next with the product pipeline?

Zepp Health plans to launch a similar number of products this year as it did last year, which was approximately nine. The company is also addressing supply chain issues that limited the availability of the Helio Stripe during the Q3 and Q4 high seasons.

A next-generation version of the Helio Stripe is currently in development. This new iteration may be released in the second half of 2026, which could help the company satisfy remaining market demand.

Regarding external pressures, the company stated that a strengthening US Dollar may actually provide a tailwind. This is due to diversified production across Asia and strong market presence in the US and Western Europe.

Frequently Asked Questions

What is Zepp Health’s revenue guidance for Q1 2026?

The company expects revenue to fall between $50 million and $55 million, representing a 30-43% increase over the previous year.

How has the company managed its debt recently?

Zepp Health has retired $58 million of debt since the start of 2023.

Why were there shortages of the Helio Stripe?

The company did not manufacture enough units to cater to the high demand during the Q3 and Q4 seasons, though they are currently resolving these supply chain issues.

Do you believe AI-driven insights will make premium wearables more essential for everyday health tracking?